World Health Organization Raises Concern Over Severe Shortage of Obesity Jabs
Fewer than a tenth of individuals who could benefit from weight-loss injections including Wegovy can access them, states the global health agency as it issues its initial advice on the drugs.
Considering over a billion individuals worldwide currently living with obesity, it is urging more widespread and fairer access to this class of drugs.
Based on forecasts, more than two billion will be living with obesity by 2030 unless action is taken.
"The new guidelines recognises that excess weight is a chronic disease that can be addressed with thorough and lifelong treatment," said its chief Tedros Adhanom Ghebreyesus.
High costs, insufficient output, and distribution challenges are major barriers to universal availability to the injections that can assist patients in reducing significant weight, explains the organization.
Weight-Loss Drug Scarcity
Even in the present best projected outlook, the manufacturing of GLP-1 therapies could only cover around 100 million people – less than 10% of eligible patients, as stated by the health organization.
The recommendation urges countries and companies to widen availability, by approaches including voluntary licensing.
Exclusive production rights on the active ingredient – the core component of a leading brand – is scheduled to end in several countries in 2026.
The Way Obesity Jabs Operate
These medications replicate a biological compound to slow digestion, reduce hunger and enhance the sense of being full so users eat less.
People typically begin shedding pounds in the initial weeks of starting on the regular doses.
Evidence suggests users may see weight return a year later of discontinuing the drug, because their usual appetite return.
Being above a healthy weight raises your chance for developing medical conditions, including diabetes, cardiovascular issues, brain attack, and specific cancers.
Obesity concerns people in every country and was linked to millions of fatalities worldwide in 2024, per the WHO.
